[ 1 ] Lo EH. A new penumbra: transitioning from injury into repair after stroke[J]. Nature Med, 2008, 14(5): 497-500.
[2]
[ 2 ] Moskowitz MA, Lo EH, Iadecola C. The Science of stroke: mechanisms in search of treatments[J]. Neuron , 2010, 67(2): 181-198.
[3]
[ 3 ] Longa EZ, Weinstein PR, Calson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J]. Stroke, 1989, 20(1): 84-86.
[4]
[ 4 ] Rosenberg GA. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases[J]. Lancet Neurol, 2009, 8 (2): 205-216.
[5]
[ 5 ] Zhang H, Trivedi A, Lee J-U, et al. Matrix metalloproteinase-9 and stromal cell-derived factor-1 act synergistically to support migration of blood-borne monocytes into the injured spinal cord[J]. J Neurosci 2011, 31(44): 15894-15903.
[6]
[ 6 ] Gu Z, Cu i J, Brown, et al. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia[J]. J Neurosci, 2005, 25(27) : 6401-6408.
[7]
[ 7 ] Lee H, Park JW, Kim SP, et al. Doxycycline inhibits matrix metalloproteinase-9 and laminin degradation after transient global cerebral ischemia[J]. Neurobiol Dis, 2009, 34(1): 189-198.
Jia F, PanYH, M ao Q, et al. Matrix metalloproteinase-9 expression and protein levels after fluid percussion injury in rats: the effect of injury severity and brain temperature[J]. J Neurotrauma, 2010, 27(6): 1059-1068.
[11]
Tong L, Smyth D, Kerr C, et al. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts[J]. Cell Signal, 2004, 16(10): 1123-1132.
[12]
Asahi M, Wang X, Mori T, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia[J]. J Neurosci, 2001, 21(19): 7724-7732.
[13]
Higashida T, K reipke CW, Rafols JA, et al. The role of hypoxia inducible factor-1 alpha, aquaporin-4, and matrix metallo roteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury[ J] . J Neuro surg, 2010, 6(10) : 1162-1168.
[14]
Esposito E, Iacono A, Muia′ C, et al. Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells[J]. J Pineal Res, 2008, 44(1):78-87.
[15]
Nelson KK, Subbaram S, Connor KM, et al. Redoxdependent matrix metalloproteinase-1 expression is regulated by JNK through Ets and AP-1 promoter motifs[J]. J Biol Chem, 2006, 281(15): 14100-14110.
[16]
English JL, Kassiri Z, Koskivirta I, et al. Individual TIMP deficiencies differentially impact pro-MMP-2 activation[J]. J Biol Chem 2006, 281(15): 10337-10346.
[17]
Van den Steen PE, Dubois B, Nelissen I, et al. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9) [J]. Crit Rev Biochem Mol Biol, 2002, 37(6): 375-536.
